Think generics is limited to ANDAs and patent challenges? Think again. Marketing and R&D must work together on creating the value proposition of the product, just like in brand pharma, writes Kathy ...
The only way to boost a price by more than 5,000% is to bend the laws of supply and demand in your favor. Turing Pharmaceuticals and its infamous chief executive, Martin Shkreli, presumably knew this ...
On Thursday, the Food and Drug Administration (FDA) publicly called out companies charged with blocking the development of generic drugs. According to generic manufacturers, brand name manufacturers ...
SILVER SPRING, Md., Nov. 21, 2017 /PRNewswire-USNewswire/ -- As we continue to confront the staggering human and economic toll created by opioid abuse and addiction, we're focused on taking actions ...
Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...
In October 2011, drug shortages were such a pressing issue in the U.S. that President Barack Obama issued an executive order urging the Food & Drug Administration to streamline the approval process ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results